Mammothbiosci Director, Manufacturing Science and Technology (MSAT) leads scale-up of lipid nanoparticle drug product process from Phase 1 to late-stage readiness. Owns technical path and manages external CDMO partners to ensure process development, technology transfer, characterization, and PPQ execution.